We are live on ! Find out more
Creative Planning

Creative Planning Portfolio holdings

AUM $147B
1-Year Est. Return 18.73%
This Fund
S&P 500
This Quarter Est. Return
-1.13%
1 Year Est. Return
+18.73%
3 Year Est. Return
+48.71%
5 Year Est. Return
+44.71%
10 Year Est. Return
+145.34%
AUM
$103B
AUM Growth
+$1.83B
Cap. Flow
+$3.67B
Cap. Flow %
3.57%
Top 10 Hldgs %
46.02%
Holding
3,718
New
534
Increased
1,981
Reduced
979
Closed
136

Sector Composition

Rank Sector Weight
1 Technology 7.11%
2 Financials 3.31%
3 Consumer Discretionary 2.07%
4 Healthcare 1.66%
5 Communication Services 1.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WB icon
3101
Weibo
WB
$1.95B
$128K ﹤0.01%
13,412
+2,269
+20% +$21.7K
PSTX
3102
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$128K ﹤0.01%
13,303
-3,657
-22% -$19.1K
TGB
3103
Trekor Metals
TGB
$2.52B
$128K ﹤0.01%
65,728
+11,953
+22% +$26.3K
RDFN
3104
DELISTED
Redfin
RDFN
$127K ﹤0.01%
16,184
+358
+2% +$3.47K
FLIC
3105
DELISTED
First of Long Island Corp
FLIC
$127K ﹤0.01%
+10,902
New +$146K
TBNK
3106
DELISTED
Territorial Bancorp Inc.
TBNK
$127K ﹤0.01%
13,044
MYE icon
3107
Myers Industries
MYE
$1.26B
$127K ﹤0.01%
+11,483
New +$138K
CMRC
3108
Commerce.com Inc Series 1
CMRC
$264M
$126K ﹤0.01%
20,563
-3,562
-15% -$22.3K
TROX icon
3109
Tronox
TROX
$981M
$126K ﹤0.01%
+12,466
New +$152K
SVM
3110
Silvercorp Metals
SVM
$2.08B
$125K ﹤0.01%
41,541
-5,693
-12% -$22.5K
RPAY icon
3111
Repay Holdings
RPAY
$344M
$125K ﹤0.01%
16,320
+2,214
+16% +$17.7K
VERV
3112
DELISTED
Verve Therapeutics
VERV
$124K ﹤0.01%
22,044
+11,637
+112% +$65.6K
BRKL
3113
DELISTED
Brookline Bancorp
BRKL
$124K ﹤0.01%
10,473
+285
+3% +$3.31K
ACEL icon
3114
Accel Entertainment
ACEL
$1.01B
$123K ﹤0.01%
11,521
-874
-7% -$9.98K
REAL icon
3115
The RealReal
REAL
$1.44B
$122K ﹤0.01%
+11,205
New +$59.6K
BTE icon
3116
Baytex Energy
BTE
$2.86B
$122K ﹤0.01%
47,426
-4,299
-8% -$12.2K
RLAY icon
3117
Relay Therapeutics
RLAY
$3.99B
$122K ﹤0.01%
+29,532
New +$161K
ZNTL icon
3118
Zentalis Pharmaceuticals
ZNTL
$329M
$122K ﹤0.01%
40,103
+28,803
+255% +$94.4K
BB icon
3119
BlackBerry
BB
$4.74B
$121K ﹤0.01%
32,036
-4,515
-12% -$12K
XPER icon
3120
Xperi
XPER
$368M
$121K ﹤0.01%
+11,787
New +$110K
APLD icon
3121
Applied Digital
APLD
$7.66B
$120K ﹤0.01%
+15,713
New +$131K
NDLS icon
3122
Noodles & Co
NDLS
$88.2M
$119K ﹤0.01%
25,803
+9,287
+56% +$67.9K
RAIL icon
3123
FreightCar America
RAIL
$280M
$119K ﹤0.01%
+13,300
New +$150K
VIRC icon
3124
Virco
VIRC
$94.7M
$118K ﹤0.01%
11,560
+20
+0.2% +$280
HLX icon
3125
Helix Energy Solutions
HLX
$1.35B
$118K ﹤0.01%
12,662
-4,166
-25% -$41.9K

Similar funds

Creative Planning's Q4 2024 Portfolio in Review

As of Q4 2024, Creative Planning held 3,718 positions worth $103B, up 1.8% from $101B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Creative Planning deployed $3.67B of net new capital in Q4 2024, opening 534 new positions and adding to 1,981 existing holdings. Its largest new stake was VanEck IG Floating Rate ETF: 1,040,413 shares worth $26.5M.

By sector, the portfolio is most concentrated in Technology at 7.1% of assets, up from 6.3% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was WisdomTree Emerging Markets SmallCap Dividend Fund, an estimated $213M trimmed.

  • Creative Planning's largest Q4 2024 buy was VanEck IG Floating Rate ETF: 1,040,413 shares worth $26.5M.
  • Creative Planning added most to Vanguard Total Bond Market in Q4 2024, an estimated $649M increase.
  • Creative Planning's biggest Q4 2024 reduction was WisdomTree Emerging Markets SmallCap Dividend Fund, cutting an estimated $213M.
  • Creative Planning fully exited iShares iBonds Dec 2024 Term Treasury ETF in Q4 2024, selling an estimated $4.5M.
  • Creative Planning's ten largest holdings make up 46% of its $103B portfolio in Q4 2024.
  • Creative Planning opened 534 new positions and closed 136 in Q4 2024.
  • Creative Planning's portfolio value rose 1.8% quarter-over-quarter to $103B.

Based on Creative Planning's 13F filing for Q4 2024, filed 14 Feb 2025.